¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

¼­¿ï¾Æ»êº´¿ø Çѱ¹°£´ãÃé¿Ü°úÇÐȸ Á¦2ȸ KPSC-KCSG °øµ¿½ÉÆ÷Áö¿ò (Á¦58Â÷ Çѱ¹ÃéÀå¿Ü°ú¿¬±¸È¸) : 2018-12-08

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
¼­¿ï¾Æ»êº´¿ø Çѱ¹°£´ãÃé¿Ü°úÇÐȸ Á¦2ȸ KPSC-KCSG °øµ¿½ÉÆ÷Áö¿ò (Á¦58Â÷ Çѱ¹ÃéÀå¿Ü°ú¿¬±¸È¸) : 2018-12-08
±³À°ÀÏÀÚ : 2018-12-08
±³À°Àå¼Ò : ¼­¿ï¾Æ»êº´¿ø ¾Æ»ê»ý¸í°úÇבּ¸¿ø ÁöÇÏ1Ãþ ´ë°­´ç  
±³À°ÁÖÁ¦ : Á¦2ȸ KPSC-KCSG °øµ¿½ÉÆ÷Áö¿ò (Á¦58Â÷ Çѱ¹ÃéÀå¿Ü°ú¿¬±¸È¸)
ÁÖÃÖ±â°ü : Çѱ¹°£´ãÃé¿Ü°úÇÐȸ
´ã´çÀÚ : À̺¸¹Ì
¿¬¶ôó : 02-2051-8299  
À̸ÞÀÏ : khbps@khbp.or.kr      
±³À°Á¾·ù : ¿Ü°ú      
Âü¼®¿¹»óÀοø : 100¸í
Èñ¸ÁÆòÁ¡ : 3Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 3 ½Ã°£ 15ºÐ  
¼¼ºÎ¼ö°­·á : 30,000¿ø      
ºñ°í       

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 12-08 ´ë°­´ç 13:20~13:30 °³È¸»ç  ÃÖÀμ®(KPSCȸÀå) 
±³À°½Ã°£ 12-08 ´ë°­´ç 13:30~13:40 Introduction of adjuvant therapy in biliary tract cancer  ·ùÇý¿ø(Ãæ³²ÀÇ´ë) 
±³À°½Ã°£ 12-08 ´ë°­´ç 13:40~13:55 Proposal of protocol(1)  ÃÖÇýÁø(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 12-08 ´ë°­´ç 13:55~14:05 Proposal of protocol(2)  Á¤Àΰæ(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 12-08 ´ë°­´ç 14:05~14:20 Standardization of surgical procedure  ¹ÚÁؼº(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 12-08 ´ë°­´ç 14:20~14:30 Clinical trial operation & funding  ¹ÚÁØ¿À(¼º±Õ°üÀÇ´ë) 
Åä·Ð 12-08 ´ë°­´ç 14:30~15:00 Discussion  ¹Ú»óÀç(±¹¸³¾Ï¼¾ÅÍ) 
È޽Ġ12-08  15:00~15:25 Coffee Break  () 
±³À°½Ã°£ 12-08 ´ë°­´ç 15:25~15:40 Update of adjuvant therapy for pancreatic cancer  ±¸µ¿È¸(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 12-08 ´ë°­´ç 15:40~15:55 Neoadjuvant therapy in borderline resectable / resectable pancreatic cancer (1)  °­Ã¢¹«(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 12-08 ´ë°­´ç 15:55~16:10 Neoadjuvant therapy in borderline resectable / resectable pancreatic cancer (2)  À̱¹Áø(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 12-08 ´ë°­´ç 16:10~16:25 Outcomes after conversion surgery after chemotherapy: personal experience and current evidence  ÀåÁø¿µ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 12-08 ´ë°­´ç 16:25~17:00 Panel discussion: Conversion surgery after chemotherapy for locally advanced or metastatic pancreatic cancer -Case presentation: Can you operate on this patient?  À¯Ã¢ÈÆ(¿ï»êÀÇ´ë) 
Åä·Ð 12-08 ´ë°­´ç 17:00~17:10 Q&A  () 
±âŸ 12-08 ´ë°­´ç 17:10~17:20 °øÁö»çÇ× ¹× ´Üü»çÁøÃÔ¿µ  ¹®ÁÖÀÍ(KPSCÃѹ«) 
±âŸ 12-08 ´ë°­´ç 17:20~17:30 Æóȸ»ç  ÃÖÀμ®(KPSCȸÀå) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û »ï¼º¼­¿ïº´¿ø 2018 ½ÉÀüµµ½ÅÈ£¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2018-12-08
´ÙÀ½±Û Àü³²´ëÇб³º´¿ø Á¦ 123Â÷ È£³²¼øȯ±âÇÐȸ Çмú´ëȸ ¹× ¿¬¼ö°­Á : 2018-12-08
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20805 ¼­¿ï 2024 ´ëÇÑ»ê°ú¸¶ÃëÇÐȸ Á¦27Â÷ Çмú´ëȸ : 2024-06-15 0 4 2024-05-27
20804 ÃæºÏ 204 ÃæûºÏµµÀÇ»çȸ Ãá°è Çмú´ëȸ : 2024-06-15 0 8 2024-05-27
20803 ºÎ»ê 2024³â Á¦7ȸ ´ëÇÑÁßȯÀÚÀçÈ°ÇÐȸ Áý´ãȸ : 2024-06-15 0 3 2024-05-27
20802 ºÎ»ê 2024³â ´ëÇÑÁßȯÀÚÀçÈ°ÇÐȸ ¿öÅ©¼¥-±â´ÉÀû Æò°¡ ¹× ÁßȯÀÚ ÀçÈ°ÀÇ ½ÇÁ¦ (¿Ü»ó ÁßȯÀÚ Æ÷ÇÔ) : 2024-06-15 0 6 2024-05-27
20801 ¼­¿ï KLASS 20Áֳ⠱â³ä 2024 ´ëÇѺ¹°­°æÀ§Àå°ü¿¬±¸È¸ Á¦27ȸ Á¤±âÇмú´ëȸ : 2024-06-15 0 3 2024-05-27
20800 °æ±â 2024³â Á¦ 3ȸ Áß¾Ó´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç °³¿øÀÇ ¿¬¼ö°­Á : 2024-06-15 0 8 2024-05-27
20799 ¼­¿ï (¿Â¶óÀÎ) 2024³âµµ ÀÓ»óÁø·áÁöħ Æò°¡À§¿ø ¾ç¼º±³À° : 2024-06-15 0 3 2024-05-27
20798 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼҾÆû¼Ò³â°ú ºÐ°úÀü¹®ÀÇ ¿¬¼ö±³À° : 2024-06-15 0 1 2024-05-27
20797 ¼­¿ï ´ëÇÑ°áÇÙ¹×È£Èí±âÇÐȸ COPD School 2024 : 2024-06-15 0 1 2024-05-27
20796 ¼­¿ï »óóÀå·ç¿¬±¸È¸ Áý´ãȸ : 2024-06-15 0 2 2024-05-27
20795 Àü³² 2024³â Àü¶ó³²µµÀÇ»çȸ Àü¹Ý±â Çмú´ëȸ : 2024-06-15 0 3 2024-05-27
20794 ¼­¿ï Ç÷°ü¿µ»ó»ý¸®¿¬±¸È¸ IPOP(Imaging and Physiology on Patients with Cardiovascular Disease) 2024 : 2024-06-15 0 1 2024-05-27
20793 ¼­¿ï ´ëÇÑõ½Ä¾Ë·¹¸£±âÇÐȸ ¾à¹°¾Ë·¹¸£±â ½ÉÆ÷Áö¾ö : 2024-06-15 0 4 2024-05-27
20792 ´ëÀü ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ ´ëÀü, ÃæûÁöȸ - Á¦3Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-15 0 1 2024-05-27
20791 ¼­¿ï Á¦51ȸ ´ëÇÑÀÓ»óÇǺÎÄ¡·á¿¬±¸È¸ ±³À°½ÉÆ÷Áö¾ö : 2024-06-15 0 5 2024-05-27
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷